Periodic Reporting for period 1 - THERAGEL (Development of a chemotherapeutic gel for glioblastoma multiforme treatment)

The Theragel project was designed to create a novel therapy for the treatment of glioblastoma multiforme (GBM), the most aggressive and common form of brain cancer. GBM typically results in death in the first 15 months after diagnosis. It accounts for 15.4% of all primary...